Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF Mutated Anaplastic Thyroid Cancer. The gene discussed is BRAF; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.